Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.870
+0.030 (1.63%)
At close: Dec 20, 2024, 4:00 PM
1.900
+0.030 (1.60%)
After-hours: Dec 20, 2024, 5:42 PM EST
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $392.09 million as of December 20, 2024. Its market cap has decreased by -7.54% in one year.
Market Cap
392.09M
Enterprise Value
193.05M
1-Year Change
-7.54%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $392.09M, a decrease of -86.39%. That is a compound annual growth rate of -27.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 399.95M |
| KalVista Pharmaceuticals | 399.79M |
| Akebia Therapeutics | 390.54M |
| Enhabit | 387.19M |
| Alpha Teknova | 385.95M |
| Nano-X Imaging | 384.49M |
| GH Research | 384.49M |
| Y-mAbs Therapeutics | 383.84M |